Vincristine and thrombocytopenia Patient Reports February 12, 2012
Vincristine Side Effects Report #4819638-2
Vincristine side effect was reported by a Physician from UNITED STATES on Oct 17, 2005. Female patient, child 4 years of age, weighting 35.27 lb, was diagnosed with rhabdomyosarcoma and was treated with Vincristine. After drug was administered, patient experienced the following side effects: anaemia, hepatomegaly, pyrexia, thrombocytopenia, transaminases increased, venoocclusive disease, weight increased. Vincristine dosage: 1.5 MG/M2 WEEKLY PU. During the same period patient was treated with DACTINOMYCIN, BACTRIM. Patient was hospitalized. Patient recovered.
Vincristine Side Effects Report #4579375-9
Vincristine side effect was reported by a Consumer or non-health professional from on Jan 25, 2005. Female patient, child 3 years of age, was diagnosed with rhabdomyosarcoma and was treated with Vincristine. After drug was administered, patient experienced the following side effects: anaemia, hepatomegaly, pyrexia, thrombocytopenia, transaminases increased, venoocclusive disease, weight increased. Vincristine dosage: 1.5 MG/M2 WEEKLY. During the same period patient was treated with ACTINOMYCIN D. Patient recovered.
Vincristine Side Effects Report #4579373-5
Vincristine side effect was reported by a Consumer or non-health professional from on Jan 25, 2005. Male patient, 15 years of age, was diagnosed with rhabdomyosarcoma and was treated with Vincristine. After drug was administered, patient experienced the following side effects: anaemia, ascites, coagulopathy, hepatomegaly, hyperbilirubinaemia, pyrexia, thrombocytopenia, transaminases increased, venoocclusive disease. Vincristine dosage: 1.5 MG/M2 WEEKLY. During the same period patient was treated with ACTINOMYCIN D. Patient recovered.
Vincristine Side Effects Report #4819636-9
Vincristine side effect was reported by a Health Professional from UNITED STATES on Oct 17, 2005. Male patient, child 12 years of age, weighting 93.70 lb, was diagnosed with rhabdomyosarcoma and was treated with Vincristine. After drug was administered, patient experienced the following side effects: anaemia, ascites, coagulopathy, hepatomegaly, hyperbilirubinaemia, pyrexia, thrombocytopenia, transaminases increased, venoocclusive disease. Vincristine dosage: 1.5 MG/M2 WEEKLY. During the same period patient was treated with DACTINOMYCIN. Patient was hospitalized. Patient recovered.
Vincristine Side Effects Report #4579377-2
Vincristine side effect was reported by a Consumer or non-health professional from on Jan 25, 2005. Female patient was diagnosed with rhabdomyosarcoma and was treated with Vincristine. After drug was administered, patient experienced the following side effects: anaemia, ascites, coagulopathy, hepatomegaly, hyperbilirubinaemia, pyrexia, thrombocytopenia, transaminases increased, venoocclusive disease. Vincristine dosage: 1.5 MG/M2 WEEKLY. During the same period patient was treated with ACTINOMYCIN D. Patient recovered.
Vincristine Side Effects Report #4819640-0
Vincristine side effect was reported by a Consumer or non-health professional from UNITED STATES on Oct 17, 2005. Female patient, weighting 16.76 lb, was diagnosed with rhabdomyosarcoma and was treated with Vincristine. After drug was administered, patient experienced the following side effects: anaemia, ascites, coagulopathy, hepatomegaly, hyperbilirubinaemia, pyrexia, thrombocytopenia, transaminases increased, venoocclusive disease. Vincristine dosage: 1.5 MG/M2 WEEKLY. During the same period patient was treated with DACTINOMYCIN. Patient was hospitalized. Patient recovered.
Vincristine Side Effects Report #4650890-2
Vincristine side effect was reported by a Consumer or non-health professional from on Apr 15, 2005. Female patient was diagnosed with multiple myeloma
and was treated with Vincristine. After drug was administered, patient experienced the following side effects: anaemia, thrombocytopenia. Vincristine dosage: 1.5 MG PER_CYCLE INJ. During the same period patient was treated with EPIRUBICIN, DEXAMETHASONE, THALIDOMIDE. Patient recovered.Vincristine Side Effects Report #4650894-X
Vincristine side effect was reported by a Consumer or non-health professional from on Apr 15, 2005. Female patient was diagnosed with multiple myeloma
and was treated with Vincristine. After drug was administered, patient experienced the following side effects: anaemia, thrombocytopenia. Vincristine dosage: 1.5 MG PER_CYCLE INJ. During the same period patient was treated with EPIRUBICIN, DEXAMETHASONE, THALIDOMIDE. Patient recovered.Vincristine Side Effects Report #5026056-3
Vincristine side effect was reported by a Physician from CANADA on May 24, 2006. Male patient, 16 years of age, was diagnosed with acute lymphocytic leukaemia and was treated with Vincristine. After drug was administered, patient experienced the following side effects: contusion, petechiae, thrombocytopenia, thrombocytopenic purpura. Vincristine dosage: unknown. During the same period patient was treated with PREDNISONE, DEXAMETHASONE, DOXORUBICIN, ELSPAR, DAUNORUBICIN, CYCLOPHOSPHAMIDE, CYTARABINE, MERCAPTOPURINE. Patient recovered.
Vincristine Side Effects Report #4674155-8
Vincristine side effect was reported by a Consumer or non-health professional from on May 24, 2005. Male patient, weighting 33.29 lb, was treated with Vincristine. After drug was administered, patient experienced the following side effects: chills, febrile neutropenia, stomatitis, thrombocytopenia. Vincristine dosage: 1.5 MG/M2 (TOP DOSE 2 MG) GIVEN I.V. ONCE PER WEEK (WEEKS 1-12, 15, 18-24, 27, 30-36, 39). During the same period patient was treated with DACTINOMYCIN, CYCLOPHOSPHAMIDE, RADIATION XRT, MESNA, BACTRIM, NEUPOGEN. Patient recovered.
Vincristine and thrombocytopenia 